Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Canine oral mucosal fibroblasts differentiate into osteoblastic cells in response to BMP-2.

Umehara K, Iimura T, Sakamoto K, Lin Z, Kasugai S, Igarashi Y, Yamaguchi A.

Anat Rec (Hoboken). 2012 Aug;295(8):1327-35. doi: 10.1002/ar.22510. Epub 2012 Jun 7.

2.

Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2.

Hirata K, Tsukazaki T, Kadowaki A, Furukawa K, Shibata Y, Moriishi T, Okubo Y, Bessho K, Komori T, Mizuno A, Yamaguchi A.

Bone. 2003 May;32(5):502-12.

PMID:
12753866
3.

Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.

Kadowaki A, Tsukazaki T, Hirata K, Shibata Y, Okubo Y, Bessho K, Komori T, Yoshida N, Yamaguchi A.

Bone. 2004 Jun;34(6):993-1003.

PMID:
15193545
4.

The effects of transplantation of osteoblastic cells with bone morphogenetic protein (BMP)/carrier complex on bone repair.

Tamura S, Kataoka H, Matsui Y, Shionoya Y, Ohno K, Michi KI, Takahashi K, Yamaguchi A.

Bone. 2001 Aug;29(2):169-75.

PMID:
11502479
5.

Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis.

Wang R, Zou Y, Yuan Z, Wang Y, Chen Y, Mao Y, Zhu ZA, Li H, Tang X, Lu J, Yi J.

Anat Rec (Hoboken). 2009 Jun;292(6):777-86. doi: 10.1002/ar.20904.

6.

Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.

Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, Kitazawa R, Komori T, Sugimoto T, Seino S, Kaji H.

Bone. 2012 Jul;51(1):158-67. doi: 10.1016/j.bone.2012.04.017. Epub 2012 May 2.

PMID:
22579779
7.

Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.

Uemura T, Ohta Y, Nakao Y, Manaka T, Nakamura H, Takaoka K.

Bone. 2010 Oct;47(4):756-65. doi: 10.1016/j.bone.2010.07.008. Epub 2010 Jul 13.

PMID:
20637325
9.

Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.

Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K.

J Biol Chem. 2004 Sep 24;279(39):40267-75. Epub 2004 May 18.

10.

RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.

Singhatanadgit W, Salih V, Olsen I.

Cell Biol Int. 2008 Nov;32(11):1362-70. doi: 10.1016/j.cellbi.2008.08.005. Epub 2008 Aug 16.

PMID:
18773965
11.

FK506 enhanced osteoblastic differentiation in mesenchymal cells.

Tang L, Ebara S, Kawasaki S, Wakabayashi S, Nikaido T, Takaoka K.

Cell Biol Int. 2002;26(1):75-84.

PMID:
11779223
12.

Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line, ROB-C26, into mature osteoblasts and adipocytes.

Kato S, Kawabata N, Suzuki N, Ohmura M, Takagi M.

Life Sci. 2009 Feb 27;84(9-10):302-10. doi: 10.1016/j.lfs.2008.12.011. Epub 2008 Dec 24.

PMID:
19146860
13.

Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.

Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tujisawa T, Nishihara T.

J Cell Physiol. 2008 Sep;216(3):844-50. doi: 10.1002/jcp.21468.

PMID:
18449905
14.

Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a.

Liu R, Ginn SL, Lek M, North KN, Alexander IE, Little DG, Schindeler A.

BMC Musculoskelet Disord. 2009 May 15;10:51. doi: 10.1186/1471-2474-10-51.

15.

Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.

Kim JL, Park SH, Jeong D, Nam JS, Kang YH.

Exp Biol Med (Maywood). 2012 Apr;237(4):417-28. doi: 10.1258/ebm.2011.011376. Epub 2012 Apr 10.

PMID:
22496431
16.
17.

De novo osteogenesis from human ligamentum flavum by adenovirus-mediated bone morphogenetic protein-2 gene transfer.

Yang IH, Kim H, Kwon UH, Lee KI, Jun JA, Kim JH, Yun CO, Park SY, Lee HM, Moon SH.

Spine (Phila Pa 1976). 2005 Dec 15;30(24):2749-54.

PMID:
16371898
18.
19.

Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.

Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM.

J Cell Biochem. 1999 Apr 1;73(1):114-25.

PMID:
10088730
20.

Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.

Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, Teruya T, Nagai K, Chung UI, Yagasaki K, Woo JT.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):260-5. doi: 10.1016/j.bbrc.2011.05.001. Epub 2011 May 6.

PMID:
21570953

Supplemental Content

Support Center